Languageservices.iconplc.com

ICON acquires PRA Health Sciences Thought Leadership ICON plc

WebICON will buy rival PRA Health Sciences Inc in a deal valued at about $12 billion, to create a contract drug research firm that can tap into the growing demand for virtual clinical trials due to the pandemic.

Actived: 6 days ago

URL: https://languageservices.iconplc.com/news-events/thought-leadership/icon-eyes-growing-virtual-clinical-trial-market/

Innovation in cardiovascular studies during COVID-19 Insights

WebThe COVID-19 pandemic has led to the implementation of more efficient trial designs and operational execution, especially with regard to cardiovascular (CV) studies.

Category: Health Go Health

Considerations for strengthening vaccine development

WebThis whitepaper presents infrastructural and strategic considerations for strengthening vaccine development so that the medical community will be prepared to respond to …

Category: Medical Go Health

Opportunities for customers

WebWith a singular focus on high quality and efficient clinical trial execution, from Phase 1 to post-approval studies, this strategic acquisition beings specific opportunities for …

Category: Health Go Health

FIRECREST Medical Animations Bringing science to life ICON plc

WebFIRECREST medical animations are highly engaging, customised videos that are a great aid for the explanation of complex scientific medical concepts or to use for health education …

Category: Medical Go Health

How Value-Based Healthcare Affects Medical Device Development

WebRead this MPO Magazine article written by ICON expert Vicki Anastasi on how value-based healthcare (VBHC) models are expected to transform the health sector.

Category: Health Go Health

ICON acquires PRA Health Sciences Thought Leadership ICON plc

WebICON has agreed to acquire PRA Health Sciences to broaden its abillity to provide decentralised and hybrid trial solutions.

Category: Health Go Health

ICON acquires PRA Health Sciences Thought Leadership ICON plc

WebIn a cash and stock transaction value of approximately $12 billion, ICON plc has announced its acquisition of PRA Health Sciences as part of a focus on innovative and high- quality …

Category: Health Go Health

Global clinical research network focused on increasing patient

WebEnhances ICON’s ability to offer customers integrated solutions of patient assessments at site and in-home for decentralised trials.

Category: Health Go Health

ICON acquires PRA Health Sciences Thought Leadership ICON plc

WebICON agreed to buy PRA Health Sciences Inc. in a $12 billion cash and stock deal that combines two research providers supporting Covid vaccine and treatment trials.

Category: Health Go Health

Health Technology Assessments (HTA) ICON plc

WebAn article in Pharmexec examining mistakes made in relation to Health Technology Assessments (HTA) and strategies to help reduce risks of future mistakes.

Category: Health Go Health

Healthcare technology leaders New Jersey 2023 Media ICON plc

WebDecentralised Clinical Trial Solutions . End-to-end services, operational model and technology to deliver customised solutions.

Category: Health Go Health

Chief Medical Officer appointment News ICON plc

WebICON announces the appointment of Dr Kristen Buck as the new Chief Medical Officer (CMO).

Category: Medical Go Health

ICON appoints Dr. James Cummings as President of ClinicalRM

WebClinicalRM is a wholly owned subsidiary of ICON plc, providing full service and functional research solutions to a range of U.S. Federal Health Agencies.

Category: Health Go Health

ICON acquires PRA Health Sciences ICON plc

WebDelivering differentiated de-centralised and hybrid clinical trial solutions through connected health platforms / wearables, a global site network and home health services.

Category: Health Go Health

Forbes names ICON one of the best employers in America

WebICON ranked top CRO in anonymous survey of 50,000 employees across 38 sectors

Category: Health Go Health

COVID-19 vaccines: Post-authorisation safety surveillance

WebThough the COVID-19 pandemic is now over, work remains ongoing to monitor vaccine effectiveness against genetic variants, the evolving safety profile and the …

Category: Health Go Health

ICON releases latest version of its Digital Platform

WebTherapeutics. We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working …

Category: Health Go Health